Thermo Fisher Scientific Extends SARS-CoV-2 GlobalAccess Sequencing Program to Support Research on New Virus Strains
Subsidized technology available as global bodies call for sequencing to confirm COVID-19 mutations
Diagnostics
Biotech Team Develops ELISA Protocol for COVID-19 IgG Antibody Detection
New detection method represents a great step forward in determining if patients have had COVID-19 and if they might still have immunity to the disease
EKF Introduces Accurate Quantitative COVID-19 Antibody Test Kit
New COVID-SeroKlir SARS-CoV-2 IgG antibody test kit is one of first to detect both the presence and precise levels of COVID-19 neutralizing antibodies
Fujirebio Diagnostics Files 510(K) with FDA for Lumipulse® G β-Amyloid Ratio (1-42/1-40) in Vitro Diagnostic Test
When cleared, Fujirebio’s FDA-designated breakthrough device is expected to be among the first commercially available in vitro diagnostics for patients being evaluated for Alzheimer’s disease in the US
New Tech Created to Aid COVID-19 Vaccine Immunity Monitoring
Diagnostic test is an accurate and reliable method for determining whether individuals are protected against COVID-19
Promising Mini Antibodies Against COVID-19 Isolated from a Llama
Preliminary results suggest anti-COVID-19 nanobodies may be effective at preventing and diagnosing infections
New Centrifuge-Like Device Concentrates, Separates Samples Faster
Novel method concentrates and separates biomedically important nanoparticles in tiny samples in less than a minute
Immediate Detection of Airborne Viruses with a Disposable Kit
Rapid and selective diagnosis of airborne viruses using disposable sampling/monitoring kits
Rheonix COVID-19™ MDx Assay Receives Expanded FDA Emergency Use Authorization to Include Saliva as a Sample Type
The ability to test saliva samples for the presence of SARS-CoV-2 simplifies the sample collection process and streamlines the testing workflow